US2016051534A1PendingUtilityA1
Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8- tetrahydro-quinoline for treating skin diseases and conditions
Est. expiryNov 10, 2031(~5.3 yrs left)· nominal 20-yr term from priority
A61P 9/00A61P 27/14A61P 27/02A61P 17/00A61K 9/0019A61K 31/4709A61K 9/0014
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 7-(1H-Imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline, or its individual enantiomers or the tautomers thereof, or a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating psoriasis in a patient, the method comprising treating the patient with a pharmaceutical composition comprising a therapeutically effective amount of 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydroquinoline, or an individual enantiomer thereof, or tautomer of the foregoing, or a pharmaceutically acceptable salt of the foregoing, thereby treating the psoriasis in the patient.
2 . The method of claim 1 , wherein the pharmaceutical composition comprises (R)-(−)-7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydroquinoline, or a tautomer thereof, or a pharmaceutically acceptable salt of the foregoing.
3 . The method of claim 1 , wherein the pharmaceutical composition comprises (S)-(+)-7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydroquinoline, or a tautomer thereof, or a pharmaceutically acceptable salt of the foregoing.
4 . The method of claim 1 , wherein the pharmaceutical composition is in a formulation suitable for topical dermatological administration.
5 . The method of claim 4 , wherein the formulation is a suspension, gel, solution, cream, lotion, ointment, foam, emulsion, microemulsion, milk, serum, aerosol, spray, dispersion, microcapsule, vesicle, microparticle, wet cloth, dry cloth or facial cloth.
6 . The method of claim 1 , wherein the pharmaceutical composition is in a formulation suitable for direct injection.Join the waitlist — get patent alerts
Track US2016051534A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.